BR0116589A - Composição herbal para angina pectoris, método para prepará-la e uso desta - Google Patents

Composição herbal para angina pectoris, método para prepará-la e uso desta

Info

Publication number
BR0116589A
BR0116589A BR0116589-5A BR0116589A BR0116589A BR 0116589 A BR0116589 A BR 0116589A BR 0116589 A BR0116589 A BR 0116589A BR 0116589 A BR0116589 A BR 0116589A
Authority
BR
Brazil
Prior art keywords
preparing
compositions
angina pectoris
herbal composition
provides
Prior art date
Application number
BR0116589-5A
Other languages
English (en)
Inventor
Yan Xijun
Naifeng
Guo
Zhixin
Zhengliang
Liu
Yab
Original Assignee
Tianjin Tasly Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Tasly Pharmaceutical filed Critical Tianjin Tasly Pharmaceutical
Publication of BR0116589A publication Critical patent/BR0116589A/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/90—Plate chromatography, e.g. thin layer or paper chromatography
    • G01N30/94—Development
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

"COMPOSIçãO HERBAL PARA ANGINA PECTORIS, MéTODO PARA PREPARá-LA E USO DESTA". Esta invenção fornece composições contendo extratos de Radix Salviae Miltiorrhizae, Radix Notoginseng e Borneol. As composições mencionadas contém notoginsenoside R~ 1~ e ginsenoside R~ g1~ que são componentes ativos para aplicações terapêuticas. Esta invenção também fornece um método de preparação das composições mencionadas e um método de identificação e determinação da quantidade de componentes efetivos individuais das composições mencionadas. Finalmente, esta invenção fornece vários usos das composições.
BR0116589-5A 2000-12-22 2001-12-18 Composição herbal para angina pectoris, método para prepará-la e uso desta BR0116589A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25805700P 2000-12-22 2000-12-22
PCT/US2001/049396 WO2002058625A2 (en) 2000-12-22 2001-12-18 Herbal composition for angina pectoris, method to prepare same and uses thereof

Publications (1)

Publication Number Publication Date
BR0116589A true BR0116589A (pt) 2003-09-23

Family

ID=22978916

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0116589-5A BRPI0116589B1 (pt) 2000-12-22 2001-12-18 Composição herbal para angina pectoris, método para prepará-la e uso desta
BR0116589-5A BR0116589A (pt) 2000-12-22 2001-12-18 Composição herbal para angina pectoris, método para prepará-la e uso desta

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BRPI0116589-5A BRPI0116589B1 (pt) 2000-12-22 2001-12-18 Composição herbal para angina pectoris, método para prepará-la e uso desta

Country Status (22)

Country Link
EP (1) EP1351698B1 (pt)
JP (1) JP5121038B2 (pt)
KR (1) KR100577498B1 (pt)
CN (1) CN100475233C (pt)
AU (1) AU2002246730B2 (pt)
BG (1) BG66440B1 (pt)
BR (2) BRPI0116589B1 (pt)
CA (1) CA2434050C (pt)
DK (1) DK1351698T3 (pt)
ES (1) ES2403240T3 (pt)
HK (1) HK1067072A1 (pt)
HU (1) HUP0303906A3 (pt)
IL (2) IL156543A0 (pt)
MX (1) MXPA03005666A (pt)
NO (1) NO331678B1 (pt)
NZ (1) NZ526995A (pt)
PL (1) PL209402B1 (pt)
RU (1) RU2310466C2 (pt)
SK (1) SK288060B6 (pt)
UA (1) UA80674C2 (pt)
WO (1) WO2002058625A2 (pt)
ZA (1) ZA200305603B (pt)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8486464B2 (en) 2000-12-22 2013-07-16 Tasly Pharmaceutical Group Co. Ltd. Herbal composition for angina pectoris, method to prepare same and uses thereof
US20040202731A1 (en) * 2003-04-08 2004-10-14 Gow Robert T. Rosmarinic acid composition
US20070059358A1 (en) 2003-07-02 2007-03-15 Tianjin Tasly Pharmaceutical Co., Ltd., China Matrix adjuvants and the drop pills prepared with them
US20050037094A1 (en) * 2003-07-31 2005-02-17 Xijun Yan Composition for heart disease, its active ingredients, method to prepare same and uses thereof
AU2004290484B8 (en) * 2003-08-28 2010-05-13 Tasly Pharmaceutical Group Co., Ltd. Treatment of Aspirin Resistance with Radix Salviae Miltiorrhizae, its extract and composition
CN100442049C (zh) * 2004-03-17 2008-12-10 天津天士力制药股份有限公司 复方丹参滴丸指纹图谱的测定方法
CN100412546C (zh) * 2004-03-17 2008-08-20 天津天士力制药股份有限公司 一种复方丹参滴丸指纹图谱的测定方法
WO2005088295A1 (fr) * 2004-03-17 2005-09-22 Tianjin Tasly Pharmaceutical Co., Ltd. Procede de controle de qualite destine aux pilules a avaler composees de danshen
CN100450501C (zh) * 2004-03-17 2009-01-14 天津天士力制药股份有限公司 一种治疗心脑血管疾病的中药制剂及其制备方法
CN1295505C (zh) * 2004-08-27 2007-01-17 广州中一药业有限公司 胃乃安胶囊的质量控制方法
CN1298340C (zh) * 2004-10-29 2007-02-07 南京生物工程与医药科技发展有限公司 治疗血瘀气滞型心胸痹痛、冠心病心绞痛的中药组合物及其制备方法
CN100390538C (zh) * 2005-06-20 2008-05-28 中国医学科学院药用植物研究所 一种达玛烷型四环三萜皂苷的检测方法
CN101084974B (zh) * 2006-06-08 2011-04-27 天津天士力之骄药业有限公司 一种党参药材的检测方法
CN101078712A (zh) * 2007-04-27 2007-11-28 上海现代中医药技术发展有限公司 扶正化瘀植物药血浆丹参素和丹酚酸b的测定方法
EP2172207B1 (en) 2007-08-02 2013-01-02 Tasly Pharmaceutical Group Co., Ltd. A pharmaceutical composition for treating diabetes and its process for preparation
US20100226935A1 (en) * 2007-09-14 2010-09-09 Leung Albert Y System and method for assessing traditional medicines
KR20110007473A (ko) * 2009-07-16 2011-01-24 씨제이제일제당 (주) 진세노사이드 강화 분획물을 포함하는 혈압 강하용 조성물
KR101016996B1 (ko) * 2010-06-01 2011-02-28 충남대학교산학협력단 진세노사이드를 함유하는 심혈관계 질환의 예방 및 치료용 조성물
EP2601958B1 (en) * 2010-08-06 2017-03-29 Tasly Pharmaceutical Group Co., Ltd. Use of salvia miltiorrhiza composition in preparing drugs for secondary prevention of coronary heart disease
CN102526380B (zh) * 2010-12-28 2014-02-05 天津同仁堂集团股份有限公司 一种冠脉通片的检测方法
TWI584813B (zh) * 2011-08-22 2017-06-01 Tasly Pharmaceutical Group Co The use of Salvia miltiorrhiza in the preparation of a medicament for secondary prevention of coronary heart disease
CN103033587A (zh) * 2011-09-30 2013-04-10 西安千禾药业有限责任公司 一种用于治疗癫痫抽搐、小儿惊风、面肌痉挛的药物的检测方法
CN102706998A (zh) * 2012-02-15 2012-10-03 江苏苏中药业集团股份有限公司 生脉注射液的质量控制方法
CN102707000B (zh) * 2012-03-14 2015-02-04 周永刚 参仙灵颗粒中人参皂苷Rg1含量的测定方法
CN102526371A (zh) * 2012-03-16 2012-07-04 安徽农业大学 兽用消炎止痛活血消肿药物及其制备方法
CN102768247A (zh) * 2012-04-11 2012-11-07 梁丽 一种治疗冠心病心绞痛药物的检测方法
CN103575819B (zh) * 2012-08-02 2016-08-03 河北以岭医药研究院有限公司 一种强心中药制剂指纹图谱的测定方法
CN103082056B (zh) * 2013-01-04 2015-03-11 云南金七制药有限公司 一种鲜三七液口服液及其制备方法
UA119750C2 (uk) 2013-07-11 2019-08-12 Таслі Фармасьютікал Груп Ко., Лтд. Склад у формі краплинної мікропігулки та спосіб його одержання
KR102189849B1 (ko) 2013-07-11 2020-12-14 타슬리 파마슈티컬 그룹 컴퍼니 리미티드 중국 전통 의약 조성물, 및 이의 제제 및 적용
TWI621443B (zh) 2013-07-11 2018-04-21 Tasly Pharmaceutical Group Co Ltd 中藥組合物及其用途、包含該中藥組合物之藥物製劑及複方丹參微滴丸劑、及該微滴丸劑的製備方法
CN103487548A (zh) * 2013-09-30 2014-01-01 邬建明 一种治疗肝炎的金马肝泰制剂的检测方法
CN103954727A (zh) * 2014-05-15 2014-07-30 山东宏济堂制药集团有限公司 金鸣片的质量控制检测方法
CN105277643B (zh) * 2014-07-17 2018-10-30 天士力医药集团股份有限公司 一种用于复方丹参滴丸的一测多评检测方法
CN108333282A (zh) * 2018-04-24 2018-07-27 山东农业大学 一种同时快速测定复方丹参片中多种酚酸类和丹参酮类成分的方法
CN108752924A (zh) * 2018-06-27 2018-11-06 邱朝转 一种尼龙增强吸附碳粉材料及其制备方法
KR102251247B1 (ko) 2018-08-16 2021-05-12 유상기 협심증 치료용 약학 조성물 및 그 제조방법
CN109507322B (zh) * 2018-12-06 2021-06-04 天津中新药业集团股份有限公司第六中药厂 一种利用指纹图谱对牙痛停滴丸进行质量控制的方法
CN110146623A (zh) * 2019-06-13 2019-08-20 山东孔圣堂制药有限公司 参苓白术丸hplc-elsd指纹图谱的建立方法及其标准图谱
CN112180022B (zh) * 2019-07-03 2023-01-20 江阴天江药业有限公司 一种炒蒺藜或蒺藜中蒺藜皂苷k含量的测定方法
CN111089919B (zh) * 2019-12-29 2022-09-06 贵州景峰注射剂有限公司 一种丹参药物的质量检测方法
CN113125627B (zh) * 2020-01-16 2022-10-18 云南雷允上理想药业有限公司 一种治疗肾病的中药组合物的有效成分检测方法
CN112345683A (zh) * 2020-11-24 2021-02-09 辽宁药联制药有限公司 Lc-ms同时测定血浆中川芎嗪与阿司匹林
CN114646691A (zh) * 2020-12-18 2022-06-21 中国科学院上海药物研究所 一种同时定量大鼠血浆中丹七通脉片15种人参皂苷类成分的分析方法
CN113125596B (zh) * 2021-04-07 2023-01-13 马应龙药业集团股份有限公司 一种高效液相色谱法测定硝酸甘油软膏中有关物质的方法
CN115453035B (zh) * 2022-10-18 2024-08-23 湖南祥民制药有限公司 一种从三七中提取高含量三七皂苷r1的方法
CN116381124B (zh) * 2023-04-11 2023-08-11 遵义市中医院 一种参芍益气活血颗粒的质量的检测方法及其应用
CN117462593A (zh) * 2023-10-25 2024-01-30 广州白云山和记黄埔中药有限公司 一种组合物在制备预防和/或治疗肺癌引起的心脏病的药物中的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4201179A1 (de) * 1992-01-17 1993-07-22 Alfatec Pharma Gmbh Wirkstoff(e) enthaltendes granulat oder pellet mit einem geruest aus hydrophilen makromolekuelen und verfahren zu seiner herstellung
CN1060399C (zh) * 1993-09-19 2001-01-10 李云峰 护心袋
US5589182A (en) * 1993-12-06 1996-12-31 Tashiro; Renki Compositions and method of treating cardio-, cerebro-vascular and alzheimer's diseases and depression

Also Published As

Publication number Publication date
EP1351698B1 (en) 2013-01-23
NO20032893D0 (no) 2003-06-23
JP5121038B2 (ja) 2013-01-16
DK1351698T3 (da) 2013-04-15
CA2434050C (en) 2014-09-16
JP2004522952A (ja) 2004-07-29
CA2434050A1 (en) 2002-08-01
SK288060B6 (sk) 2013-03-01
KR20030070906A (ko) 2003-09-02
EP1351698A2 (en) 2003-10-15
CN1520307A (zh) 2004-08-11
EP1351698A4 (en) 2004-11-03
NO20032893L (no) 2003-08-21
NZ526995A (en) 2007-02-23
AU2002246730B2 (en) 2006-09-07
PL362562A1 (en) 2004-11-02
MXPA03005666A (es) 2004-12-03
HUP0303906A3 (en) 2005-05-30
KR100577498B1 (ko) 2006-05-10
WO2002058625A2 (en) 2002-08-01
NO331678B1 (no) 2012-02-20
RU2003123095A (ru) 2005-01-10
BRPI0116589B1 (pt) 2018-07-03
BG66440B1 (bg) 2014-08-29
HK1067072A1 (en) 2005-04-01
PL209402B1 (pl) 2011-08-31
WO2002058625A3 (en) 2003-03-06
SK9172003A3 (en) 2004-03-02
ZA200305603B (en) 2004-04-22
BG108001A (bg) 2004-11-30
CN100475233C (zh) 2009-04-08
HUP0303906A2 (hu) 2004-05-28
IL156543A (en) 2012-07-31
ES2403240T3 (es) 2013-05-16
RU2310466C2 (ru) 2007-11-20
IL156543A0 (en) 2004-01-04
UA80674C2 (en) 2007-10-25

Similar Documents

Publication Publication Date Title
BR0116589A (pt) Composição herbal para angina pectoris, método para prepará-la e uso desta
MXPA03006927A (es) Composicion para enfermedad cardiaca, metodo para prepararla y sus usos.
DK1370271T3 (da) Fremgangsmåde til fremstilling af en matrinholdigt plantepræparat
BR0209689A (pt) Uso de fragmento de hmg como agente anti-inflamatório
DK1663103T3 (da) Sammensætninger af botaniske ekstrakter til cancerterapi
AR020055A1 (es) Una composicion farmaceutica o cosmetica que contiene una sustancia de esmalte activa, usos de dicha composicion y un metodo para preparar la misma.
DK0835120T3 (da) Farmaceutiske sammensætninger indeholdende aktive ingredienser på basis af urter, fremgangsmåde til fremstilling af sammens
MXPA05013232A (es) Composicion en forma de pulverizador que comprende un activo farmaceutico, al menos una silicona volatil y una fase aceitosa no volatil.
BR0009982A (pt) Material voltado para o corpo possuindo uma superfìcie externa que possui uma composição que melhora a barreira da pele e processo de produção do mesmo
EE200000225A (et) Arüüloksüalküüldialküülamiinid, nende valmistamismeetodid ja farmatseutiline kompositsioon
ES2165723T3 (es) Composiciones farmaceuticas conteniendo mupirocina.
DK1392335T3 (da) Farmaceutisk og/eller kosmetisk sammensætning til behandling af lokal adipositas og cellulite
BR0106687A (pt) Composição para intensificar a permeação de agentes tópicos à pele
ATE275916T1 (de) Parfümkomposition mit duftsequenz
DK0847755T3 (da) Anvendelse af en ekstrakt af cimicifuga racemosa
BR0109846A (pt) Uso de uma composição que compreende um anticorpo ou um fragmento de ligação de antìgeno deste, e conjunto
NO20060832L (no) Behandling av aspirin resistens med radix salvie miltiorrhiaze, dens ekstrakt og sammensetning
DE60008798D1 (de) Extrakt von undifferenzierten zellen einer pflanze der gattung leontopodium und ihn enthaltende zusammensetzungen
ES2192704T3 (es) Innovadoras composiciones farmaceuticas.
BR9911917A (pt) Composições compreendendo análogos de gaba e cafeìna
PA8449301A1 (es) Composiciones farmaceuticas
DK0824356T3 (da) Farmaceutiske sammensætninger til behandling af alkoholafhængighed
BR0108274A (pt) Indução de difenil éter de resistência sistêmica em plantas
BR9911639A (pt) Composições capilares não enxaguáveis contendo um diol
BR9815368A (pt) Extrato e preparado cosmético

Legal Events

Date Code Title Description
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT. CL. : A61K 35/78, G01N 31/00.

Ipc: A61K 36/185 (2006.01), A61K 36/537 (2006.01), A61K

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25F Entry of change of name and/or headquarter and transfer of application, patent and certif. of addition of invention: change of name on requirement

Owner name: TIANJIN TASLY PHARMACEUTICAL CO. (CN)

Free format text: A FIM DE ATENDER A ALTERACAO DE NOME REQUERIDA ATRAVES DA PETICAO NO 18130022852, DE 04/07/2013, E NECESSARIO REAPRESENTAR O DOCUMENTO DE ALTERACAO DE NOME COM TRADUCAO JURAMENTADA E DEVIDAMENTE CONSULARIZADO.

B25D Requested change of name of applicant approved

Owner name: TASLY PHARMACEUTICAL GROUP CO., LTD. (CN)

B25G Requested change of headquarter approved

Owner name: TASLY PHARMACEUTICAL GROUP CO., LTD. (CN)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 19A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2610 DE 12-01-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.